This article is more than 5 years old. Information may no longer be current.
Epi-LASIK devices granted Korean marketing approval
MELBOURNE, Australia — Devices used in performing the epi-LASIK procedure have been granted marketing approval by Korean regulators, according to the devices’ marketer.
The Centurion SES System and the EpiEdge disposable separator have been granted approval by the Korean Food and Drug Administration, said a press release from Norwood Abbey Ltd., the products’ marketer.
The Norwood Abbey press release said South Korean distributor, DaMool Systec Corp. will begin filling customer orders for the Epi-LASIK system in the second half of this year. According to Norwood Abbey, South Korea “accounts for several hundred thousand” laser vision correction procedures a year and has an estimated 300 laser centers.
Norwood Abbey acquired all rights to the Epi-LASIK system from CIBA Vision earlier this year.